• Global Market News
  • Posts
  • Tariff Truce, China's Virus Outbreak, Cooling Inflation & a New Musk-Apple Showdown

Tariff Truce, China's Virus Outbreak, Cooling Inflation & a New Musk-Apple Showdown

From tariffs to tech wars, today’s headlines could shake portfolios — here’s what you need to know now.

in partnership with

Med-X

Med-X is gearing up for a possible Nasdaq listing (ticker: MXRX). But the real opportunity is now—before they hit the big stage.

Their all-natural pesticides have outperformed chemical brands in independent lab tests, providing safer solutions without sacrificing results. Their products are already available through e-commerce giants like Walmart, Amazon, and Kroger, and they plan to expand internationally.

With $6.4M in sales in just four years, they’re getting ready for the next step. Become a Med-X shareholder before their Nasdaq plans unfold.

This is a paid advertisement for Med-X’s Regulation A+ Offering. Please read the offering circular at https://invest.medx-rx.com/

A fast-spreading mosquito-borne virus has caught health officials’ attention — and travel, tourism, and pharmaceutical stocks could feel the ripple effects.

The Kennedy administration just canceled 22 mRNA vaccine development projects. Biotech giants like Pfizer and Moderna are reeling — and so are investors. Is this a pivot to safer vaccines, or a political earthquake in public health?

Markets just got a brief reprieve from escalating tariffs. But this extension is no guarantee of peace — here’s what’s next for equities, commodities, and global trade flows.

Elon Sues Apple

Elon Musk is going after Apple over how it ranks AI apps — a fight that could reshape the mobile AI economy and create unexpected winners in tech stocks.

👉 That’s today’s Global Market News Daily Brief—the most important headlines, curated for our 199,000+ investor subscribers.

No spin. No noise. Just what matters for your portfolio.

Stay sharp,
— The Global Market News Team

Know what you own, and know why you own it.

-Peter Lynch

Styled Text

You are receiving this email because you opted in to receive updates from Global Market News. This newsletter may contain sponsored content or advertisements. Information provided is for informational purposes only and should not be considered financial or investment advice. Always consult a financial advisor before making investment decisions.